. . . . . . . "[This review will focus on the second-wave DAAs including protease inhibitors (PI), nucleotide inhibitors, and NS5B inhibitors combined with PEG-IFN and RBV for both treatment-na�ve and treatment-experienced genotype 1 hepatitis C virus (HCV-1) infected patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:09+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .